Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1982;228(1):1-16.
doi: 10.1007/BF00313405.

Therapeutic drug monitoring: a comprehensive and critical review of analytical methods for anticonvulsive drugs

Review

Therapeutic drug monitoring: a comprehensive and critical review of analytical methods for anticonvulsive drugs

A H Kumps. J Neurol. 1982.

Abstract

In the last 20 years, there has been considerable improvement in the determination of anticonvulsive drugs in body fluids. Gas-liquid chromatography, high-performance liquid chromatography and immunological methods (radio-, enzyme-, fluoro-, and nephelo-immunoassays) have progressively supplanted spectrophotometry and thin-layer chromatography. As the number of publications shows, these methods have included a great variety of procedures. At present, gas-liquid chromatography and enzyme-immunoassays are routinely performed, awaiting a wider spread of liquid chromatography and other immunological techniques. This paper is a comprehensive review of the analytical literature on the determination of phenobarbitone, primidone, phenytoin, carbamazepine, valproic acid, ethosuximide, clonazepam, and some of their metabolites in physiological fluids. Gas-liquid chromatographic methods are more particularly reviewed. In order to facilitate the choice between these procedures, a critical selection of the techniques is given and recommendations are made. Emphasis is laid on technical problems encountered with the assays, as well as the need for a rigorous analytical assessment and internal and external quality controls. This review is completed by considerations on the determination of the free drug fraction and on sample collection and storage.

PubMed Disclaimer

References

    1. J Chromatogr. 1979 Apr 21;172:279-86 - PubMed
    1. J Immunol Methods. 1979;29(1):85-9 - PubMed
    1. Biomed Mass Spectrom. 1978 Aug;5(8):477-82 - PubMed
    1. J Chromatogr. 1978 Sep 1;146(2):361-2 - PubMed
    1. Clin Chem. 1975 May;21(6):751-4 - PubMed

Substances

LinkOut - more resources